MiHIN

EConsent Workflows Must Evolve to Support Interoperability and Health Equity

Former U.S. CTO Aneesh Chopra will moderate a webinar on April 16 at 1pm ET on eConsent and interoperability with DocuSign, Velatura, Mid-State Health Network and Southwest Michigan Behavioral Health.

By Stephanie Baum

A Personalized Approach to Medication Nonadherence

At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

By PurpleLab